Biocardia Inc (BCDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,913 | -2,267 | -11,571 | -9,499 | -6,925 |
| Depreciation Amortization | 36 | 19 | 84 | 64 | 43 |
| Accounts receivable | 87 | 29 | 115 | 86 | 86 |
| Other Working Capital | 505 | 451 | 129 | 209 | 417 |
| Other Operating Activity | 443 | 238 | 1,269 | 1,017 | 668 |
| Operating Cash Flow | $-2,842 | $-1,530 | $-9,974 | $-8,123 | $-5,711 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3 | N/A | -12 | -12 | -12 |
| Investing Cash Flow | $-3 | $N/A | $-12 | $-12 | $-12 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 3,315 | 1,466 | 4,388 | 3,042 | 2,665 |
| Other Financing Activity | -152 | -90 | -662 | -435 | 0 |
| Financing Cash Flow | $3,163 | $1,376 | $3,726 | $2,607 | $2,665 |
| Beginning Cash Position | 1,103 | 1,103 | 7,363 | 7,363 | 7,363 |
| End Cash Position | 1,421 | 949 | 1,103 | 1,835 | 4,305 |
| Net Cash Flow | $318 | $-154 | $-6,260 | $-5,528 | $-3,058 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,842 | -1,530 | -9,974 | -8,123 | -5,711 |
| Capital Expenditure | -3 | N/A | -12 | -12 | -12 |
| Free Cash Flow | -2,845 | -1,530 | -9,986 | -8,135 | -5,723 |